Pharma firm Pfizer Ltd on Saturday reported a 61.01 per cent rise in net profit to Rs 154.25 crore for the July-September quarter compared to that of Rs 95.80 crore in the same quarter of last year.
Its revenue from operations was at Rs 567.06 crore in the quarter, up 9.10 per cent compared to Rs 519.74 crore in the year-ago quarter, Pfizer said in a BSE filing.
Pfizer’s total expenses were at Rs 430.63 crore during the period under review as against Rs 407.92 crore, up 5.56 per cent.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.